New Commission study fuels generic drugs industry ‘manufacturing dispute’
The European Commission launched on Thursday (12 October) a public consultation on supplementary protection certificates for pharmaceutical products and the so-called Bolar patent research exemption.
View ArticleGreek government on collision course with pharmaceutical companies over...
Several pharmaceutical companies in Greece have threatened to stop supplying the market with innovative drugs and said they could even withdraw existing drugs as a result of an obligatory “discount”...
View ArticlePharmaceutical company withdraws oncology drug from Greek market
A multinational pharmaceutical company has decided to withdraw an innovative oncology medicine from the Greek market, claiming that its price has fallen more than 50% because of the government’s...
View ArticleGreek health minister fumes at pharmaceutical company after drug withdrawal
The Greek ministry of health reacted strongly to the decision of a pharmaceutical company to withdraw a drug from the market for “viability” reasons, saying it will not accept any blackmail.
View ArticlePharmaceutical company gives free access to drug after clash with Greek...
Following a clash with the Greek government over its decision to withdraw a cancer drug from the market, ROCHE, a Swiss multinational company, ultimately decided to make the drug available to patients...
View ArticleEMA relocation should consider the wellbeing of all Europeans
The competition for the European Medicines Agency is not a horse race but the first concrete, effective decision the EU has to make in the wake of Brexit - and one with long-lasting consequences. A...
View ArticleEU health Commissioner Vytenis Andriukaitis discusses Europe’s superbug...
Vytenis Andriukaitis, European Commissioner for Health and Food Safety, joined Brian Maguire to discuss Europe’s fight against the deadly rise of superbugs.
View ArticleAndriukaitis: National health systems need ‘fundamental reform’
EU countries could save money and lives by increasing investment in disease prevention and health promotion, the European Commission said on Thursday (23 November), stressing that good health policy...
View ArticleAthens brings its dispute with pharma industry to the EU Council
The next EU Health Council on 8 December will discuss the “lack of drug availability in Greece”, amid mounting tensions between the leftist government in Athens and the pharmaceutical companies.
View ArticleUK and pharma industry call for transition period for medicines supply
With Brexit barely 15 months away, the UK government, as well as the European and British life science industry, is calling for a transition period on the regulation and supply of medicines in order to...
View ArticleCelgene boss: Chronic diseases will bankrupt Europe if incentives are dropped
Alzheimers, diabetes, cancer and other non-communicable diseases will bankrupt Europe if we don’t keep the incentive frameworks alive and well, Mark Alles told EURACTIV.com in an interview.
View ArticleDrug pricing debate to take place in heated atmosphere
Following a Greek government request, the Employment, Social Policy, Health and Consumer Affairs Council (EPSCO) will discuss on Friday (8 December) a recent dispute between Athens and ROCHE, a Swiss...
View ArticleDrugs incentives have saved lives in Europe [Promoted content]
Without strong incentives to spur continued investment in medical innovation, we cannot hope to ensure the sustainability of European healthcare systems and fulfil the promise of our great union,...
View ArticleCommission reassures ‘worried’ member states on Health Technology Assessment
The Commission’s upcoming proposal on Health Technology Assessment (HTA) will focus on clinical aspects and leave member states to decide on economic or ethical parts, a European Commission...
View ArticleStakeholders call for more transparent meetings between pharma and EMA
Public health organisations and EU lawmakers say the closed-door meetings before the submission of a new drug between the pharma industry and the European Medicines Agency (EMA), a key player in the...
View ArticleHealth tech bill to kick off busy policy agenda in 2018
The European Commission will propose a new law on Health Technology Assessments to kick off a busy EU health agenda in 2018.
View ArticleCommission reforms meet with national ‘silence’, says frustrated EU health chief
EU governments are meeting the Commission's proposals to reform health systems with "silence", an exasperated Health Commissioner Vytenis Andriukaitis said on Thursday (25 January), pleading for more...
View ArticleHealth expert: Europe should not put its dominant pharma innovation at risk
The European Union should not create an environment more favourable to generics compared to the innovative pharmaceuticals, as it risks weakening Europe’s overall global strength in pharmaceuticals and...
View ArticleFake medicines? Face 15 year jail term
Twenty-one EU countries have made falsifying medicines a criminal offence, carrying a potential jail sentence of 15 years, according to a new report published on Friday (26 January) by the European...
View ArticleEU unveils health technology bill
The European Commission unveiled plans for a pan-EU Health Technology Assessment (HTA) law on Wednesday (31 January), with EU health chief Vytenis Andriukaitis promising that they would help patients...
View Article
